Amneal Pharmaceuticals has introduced five new generic drugs, the company said.
The Senate was expected to take up a bill designed to secure the drug supply chain and establish a list of "do not compound" medications, but left for recess Friday without voting on it.
The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.
The Food and Drug Administration has approved a Perrigo generic drug for treating dermatitis, the company said Wednesday.
Drug maker Pfizer is planning to split its commercial division into three business lines that will separate its branded and generic products, the company said Monday.
Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.
Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said.
U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.
A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.
Anda VP purchasing Marc Falkin wrote in an email to coworkers and friends that he would begin working for Actavis as VP marketing, pricing and contract operations for the Parsippany, N.J.-based drug maker's generics business.